The patents detail new methods to treat resistant cancer and fibrosis, and will be filed with IP Australia under the company’s wholly owned subsidiary, Propanc Pty Ltd. These discoveries emerged from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback